What is Borregaard ASA?
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally.
0QB7 · Verdict
Solid reward · moderate risk
0QB7 stands out on balance sheet and profitability, but watch the cash flow signal.
Based on 75% data coverage
0QB7 · Verdict
Current ratio 1.46
11% return on equity
Above average
Below average
Model-based scoring. For information only — not financial advice.
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company is listed on the LSE in UK, with a market capitalisation of 20.70B.
The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.